The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Natera
Speakers' Bureau - Agendia; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Merck; Natera; Pfizer; Stemline Therapeutics
Clinical performance of Signatera Genome assay in a cohort of patients (pts) with solid tumors.
 
Mridula George
Research Funding - Incyte; Oncolytics
Other Relationship - Oncology Learning Network
 
Gary Schwartz
No Relationships to Disclose
 
Wassim Mchayleh
No Relationships to Disclose
 
Vitaly Margulis
No Relationships to Disclose
 
Alan Tan
Stock and Other Ownership Interests - Adaptimmune; Aprea AB; Bluebird Bio; Editas Medicine; FATE Therapeutics; Fusion Pharmaceuticals; ImmunityBio; Iovance Biotherapeutics; MEI Pharma; natera; RAPT Therapeutics
Honoraria - Bristol Myers Squibb Foundation; EMD Serono; Exelixis; Gilead Sciences; Merck; Myovant Sciences; natera; Seagen
Consulting or Advisory Role - Exelixis; Foundation Medicine; Myovant Sciences
Speakers' Bureau - bristol myers squibb; EMD Serono; Exelixis; Gilead Sciences; Merck; natera
 
Sumedha Sudhaman
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Travel, Accommodations, Expenses - Natera
 
Carly Bess Scalise
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Bharat Sridhar
Employment - Natera
Stock and Other Ownership Interests - Natera
Patents, Royalties, Other Intellectual Property - Listed as inventor on US11155858B2 assigned to Singular Genomics Inc
 
Jordan Feeney
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Wilson Tan
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Alexander Hsieh
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
 
Anastasia Butskova
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Travel, Accommodations, Expenses - Natera
 
Jose Ortega
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Patents, Royalties, Other Intellectual Property - RMD detection algorithm (Inst)
 
Matthew Rabinowitz
Employment - Marble Therapeutics; MyOme; Natera
Leadership - Marble Therapeutics; Myome; Natera
Stock and Other Ownership Interests - Marble Therapeutics; Myome; Natera
Consulting or Advisory Role - Marble Therapeutics; MyOme; Natera
Research Funding - Myome; Natera
Patents, Royalties, Other Intellectual Property - MyOme; Natera
Travel, Accommodations, Expenses - MyOme; Natera
 
Himanshu Sethi
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Patents, Royalties, Other Intellectual Property - Patents
Travel, Accommodations, Expenses - Natera
 
Adam ElNaggar
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Michael Krainock
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Angel Rodriguez
Employment - Natera
Leadership - Natera
Stock and Other Ownership Interests - Natera
 
Minetta Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Matthew Galsky
Consulting or Advisory Role - Abbvie; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Curis; Daiichi Sankyo Europe GmbH; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792